Biomarker ID | 1148 |
PMID | 23818401 |
Year | 2013 |
Biomarker | C-Reactive Protein (CRP) |
Biomarker Basis | Concentration Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Higher levels associated with shorter biochemical failure-free survival (Both for patients with Post- radical Prostatectomy and Definitive Radiotherapy) |
Odds Ratio/Hazard Ratio/Relative Risk | Definitive Radiation Therapy: HR: 2.03 (95% CI: 1.19-3.47) |
Effect on Pathways | NA |
Experiment | Biochemical Failure Free survival |
Type of Biomarker | Prognostic |
Cohort | 206 patients who received radiation therapy for adenocarcinoma of the prostate were included in the study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p = 0.009 |
Method Used | NA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |